Article info

Original research
Cost-effectiveness analysis of 3 months of weekly rifapentine and isoniazid compared to isoniazid monotherapy in a Canadian arctic setting

Authors

  1. Correspondence to Dr Christopher Pease; Cpease{at}toh.ca
View Full Text

Citation

Pease C, Alvarez G, Mallick R, et al
Cost-effectiveness analysis of 3 months of weekly rifapentine and isoniazid compared to isoniazid monotherapy in a Canadian arctic setting

Publication history

  • Received November 30, 2020
  • Revised April 1, 2021
  • Accepted April 14, 2021
  • First published May 13, 2021.
Online issue publication 
May 13, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.